ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,937Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 117

$500K Total Retail Price of All Prescriptions

Rank: 33 out of 117

278 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 278 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 278 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 378 341 1 3
LEVOTHYROXINE SODIUM 370 343 2 2
LISINOPRIL 267 246 3 4
WARFARIN SODIUM 265 261 4 9
SIMVASTATIN 260 234 5 1
AMLODIPINE BESYLATE 230 211 6 5
DONEPEZIL HCL 223 223 7 10
ATORVASTATIN CALCIUM 218 218 8 15
METOPROLOL SUCCINATE 216 210 9 12
METOPROLOL TARTRATE 205 205 10 8
NAMENDA 201 200 11 14
OMEPRAZOLE 201 201 11 6
CITALOPRAM HBR 199 192 13 19
ALENDRONATE SODIUM 137 112 14 21
HYDROCODONE-ACETAMINOPHEN 136 102 S3 15 7
FAMOTIDINE 130 109 16 38
SERTRALINE HCL 125 121 17 22
CARVEDILOL 109 109 18 24
ENALAPRIL MALEATE 108 96 19 33
RISPERIDONE 96 96 20 39
ZOLPIDEM TARTRATE 92 62 21 27
QUETIAPINE FUMARATE 91 87 22 36
ISOSORBIDE MONONITRATE ER 88 88 23 52
GABAPENTIN 88 80 23 16
METFORMIN HCL 87 74 25 11
POTASSIUM CHLORIDE 86 70 26 17
BACLOFEN 80 23 27 120
TRAZODONE HCL 79 76 28 44
TAMSULOSIN HCL 79 75 28 28
CLOPIDOGREL 79 71 28 30
DIVALPROEX SODIUM 77 74 31 65
MIRTAZAPINE 65 60 32 25
NYSTATIN-TRIAMCINOLONE 63 47 33 99
FLUOXETINE HCL 60 47 34 87
SPIRONOLACTONE 60 57 34 53
PANTOPRAZOLE SODIUM 57 57 36 26
PRAVASTATIN SODIUM 55 55 37 29
HYDROCHLOROTHIAZIDE 54 50 38 13
PLAVIX 54 54 38 47
FENTANYL 54 22 S2 38 41
LANTUS 54 54 38 43
GLYBURIDE 54 42 R 38 88
DIGOXIN 52 52 43 35
ATENOLOL 51 39 44 20
KLOR-CON M20 51 51 44 34
LEVETIRACETAM 50 27 46 71
PRIMIDONE 50 50 46 183
CIPROFLOXACIN HCL 50 39 46 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.